RGEN
Repligen Corp.
Halal Rating :
Last Price
$160.60
Last updated:
Market Cap
-
7D Change
1.36%
1 Year Change
-12.82%
Company Overview
Industries
Exchange
Next Earnings Date
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing. Their products enable the manufacturing process for biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies.
The company's primary focus is on providing critical technologies and products that improve efficiency and quality in bioprocessing workflows, from pre-clinical drug development to commercial-scale manufacturing.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $154.87m | $167.82m | - | $5.12m | 0.00% | 3.05% |
| June 30, 2024 | $158.84m | $158.49m | - | $5.12m | 0.00% | 3.23% |
| March 31, 2024 | $153.18m | $154.46m | - | $5.03m | 0.00% | 3.26% |
Company Impact
Help us evaluate Repligen Corp.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.